Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss

References

• World Health Organization The SuRF Report 2 Geneva, Switzerland World Health Organization 2005
   Google Scholar
• Wang Y Beydoun MA The obesity epidemic in the United States–gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis Epidemiol Rev 2007 29 6 28 17510091
   PubMed Web of Science ®Google Scholar
• Rodgers RJ Tschop MH Wilding JP Anti-obesity drugs: past, present and future Dis Model Mech 2012 5 621 626 22915024
   PubMed Web of Science ®Google Scholar
• Carotenuto M Bruni O Santoro N Waist circumference predicts the occurrence of sleep-disordered breathing in obese children and adolescents: a questionnaire-based study Sleep Med 2006 7 357 361 16713341
   PubMed Web of Science ®Google Scholar
• Carotenuto M Santoro N Grandone A The insulin gene variable number of tandemrepeats (INS VNTR) genotype and sleep disordered breathing in childhood obesity J Endocrinol Invest 2009 32 752 755 19574727
   PubMed Web of Science ®Google Scholar
• World Health Organization Obesity: Preventing and Managing the Global Epidemic WHO/NUT/NCD/981 Geneva, Switzerland World Health Organization 1997
   Google Scholar
• O’Dea K Overview of the thrifty genotype hypothesis Asia Pac J Clin Nutr 1995 4 339 340 24394420
   PubMedGoogle Scholar
• Kopelman PG Obesity as a medical problem Nature 2000 404 635 643 10766250
   PubMed Web of Science ®Google Scholar
• Fontaine KR Redden DT Wang C Westfall AO Allison DB Years of life lost due to obesity JAMA 2003 289 187 193 12517229
   PubMed Web of Science ®Google Scholar
• Haslam DW James WP Obesity Lancet 2005 366 1197 1209 16198769
   PubMed Web of Science ®Google Scholar
• Esposito M Antinolfi L Gallai B Executive dysfunction in children affected by obstructive sleep apnea syndrome: an observational study Neuropsychiatr Dis Treat 2013 9 1087 1094 23976855
   PubMedGoogle Scholar
• Carotenuto M Esposito M Parisi L Depressive symptoms and childhood sleep apnea syndrome Neuropsychiatr Dis Treat 2012 8 369 373 22977304
   PubMed Web of Science ®Google Scholar
• Flegal KM Graubard BI Williamson DF Gail MH Cause-specific excess deaths associated with underweight, overweight, and obesity JAMA 2007 298 2028 2037 17986696
   PubMed Web of Science ®Google Scholar
• Kushner RF Weight loss strategies for treatment of obesity Prog Cardiovasc Dis 2014 56 465 472 24438739
   PubMed Web of Science ®Google Scholar
• Verrotti A Carotenuto M Altieri L Migraine and obesity: metabolic parameters and response to a weight loss programme Pediatr Obes Epub 2014 7 3
   Web of Science ®Google Scholar
• Verrotti A Agostinelli S D’Egidio C Impact of a weight loss program on migraine in obese adolescents Eur J Neurol 2013 20 394 397 22642299
   PubMed Web of Science ®Google Scholar
• Sharma AM Padwal R Obesity is a sign–over-eating is a symptom: an aetiological framework for the assessment and management of obesity Obes Rev 2010 11 362 370 19922430
   PubMed Web of Science ®Google Scholar
• Dieguez C Vazquez MJ Romero A Lopez M Nogueiras R Hypothalamic control of lipid metabolism: focus on leptin, ghrelin and melanocortins Neuroendocrinology 2011 94 1 11 21576929
   PubMed Web of Science ®Google Scholar
• Hnasko TS Szczypka MS Alaynick WA During MJ Palmiter RD A role for dopamine in feeding responses produced by orexigenic agents Brain Res 2004 1023 309 318 15374756
   PubMed Web of Science ®Google Scholar
• Cawley EI Park S aan het Rot M Dopamine and light: dissecting effects on mood and motivational states in women with subsyndromal seasonal affective disorder J Psychiatry Neurosci 2013 38 388 397 23735584
   PubMed Web of Science ®Google Scholar
• Singh M Mood, food, and obesity Front Psychol 2014 5 925 25225489
   PubMed Web of Science ®Google Scholar
• Lage R Dieguez C Vidal-Puig A Lopez M AMPK: a metabolic gauge regulating whole-body energy homeostasis Trends Mol Med 2008 14 539 549 18977694
   PubMed Web of Science ®Google Scholar
• Guyenet SJ Schwartz MW Clinical review. Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity J Clin Endocrinol Metab 2012 97 745 755 22238401
   PubMed Web of Science ®Google Scholar
• Bluher M Clinical relevance of adipokines Diabetes Metab J 2012 36 317 327 23130315
   PubMedGoogle Scholar
• Seoane LM Lopez M Tovar S Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus Endocrinology 2003 144 544 551 12538615
   PubMed Web of Science ®Google Scholar
• Turer AT Scherer PE Adiponectin: mechanistic insights and clinical implications Diabetologia 2012 55 2319 2326 22688349
   PubMed Web of Science ®Google Scholar
• Sell H Bluher M Kloting N Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro Diabetes Care 2013 36 4083 4090 24130353
   PubMed Web of Science ®Google Scholar
• Kloting N Fasshauer M Dietrich A Insulin-sensitive obesity Am J Physiol Endocrinol Metab 2010 299 E506 E515 20570822
   PubMed Web of Science ®Google Scholar
• Oh IS Shimizu H Satoh T Identification of nesfatin-1 as a satiety molecule in the hypothalamus Nature 2006 443 709 712 17036007
   PubMed Web of Science ®Google Scholar
• Kloting N Kovacs P Kern M Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects Diabetologia 2011 54 1819 1823 21465327
   PubMed Web of Science ®Google Scholar
• Gaich G Chien JY Fu H The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes Cell Metab 2013 18 333 340 24011069
   PubMed Web of Science ®Google Scholar
• Fisher FM Kleiner S Douris N FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis Genes Dev 2012 26 271 281 22302939
   PubMed Web of Science ®Google Scholar
• Canto C Auwerx J PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure Curr Opin Lipidol 2009 20 98 105 19276888
   PubMed Web of Science ®Google Scholar
• Tseng YH Kokkotou E Schulz TJ New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure Nature 2008 454 1000 1004 18719589
   PubMed Web of Science ®Google Scholar
• Townsend KL Suzuki R Huang TL Bone morphogenetic protein 7 (BMP7) reverses obesity and regulates appetite through a central mTOR pathway FASEB J 2012 26 2187 2196 22331196
   PubMed Web of Science ®Google Scholar
• Bostrom P Wu J Jedrychowski MP A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 2012 481 463 468 22237023
   PubMed Web of Science ®Google Scholar
• Roca-Rivada A Castelao C Senin LL FNDC5/irisin is not only a myokine but also an adipokine PLoS One 2013 8 e60563 23593248
   PubMed Web of Science ®Google Scholar
• Raschke S Elsen M Gassenhuber H Evidence against a beneficial effect of irisin in humans PLoS One 2013 8 e73680 24040023
   PubMed Web of Science ®Google Scholar
• Timmons JA Baar K Davidsen PK Atherton PJ Is irisin a human exercise gene? Nature 2012 488 E9 E10 discussion E10–E11 22932392
   PubMed Web of Science ®Google Scholar
• Neary MT Batterham RL Gut hormones: implications for the treatment of obesity Pharmacol Ther 2009 124 44 56 19560488
   PubMed Web of Science ®Google Scholar
• Folgueira C Seoane LM Casanueva FF The brain-stomach connection Front Horm Res 2014 42 83 92 24732927
   PubMed Web of Science ®Google Scholar
• Inui A Asakawa A Bowers CY Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ FASEB J 2004 18 439 456 15003990
   PubMed Web of Science ®Google Scholar
• Cummings DE Overduin J Gastrointestinal regulation of food intake J Clin Invest 2007 117 13 23 17200702
   PubMed Web of Science ®Google Scholar
• Kojima M Hosoda H Date Y Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 1999 402 656 660 10604470
   PubMed Web of Science ®Google Scholar
• Seoane LM Al-Massadi O Barreiro F Dieguez C Casanueva FF Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system J Endocrinol Invest 2007 30 RC22 RC25 17993760
   PubMed Web of Science ®Google Scholar
• Zhang X Li W Li P Intraportal infusion of ghrelin could inhibit glucose-stimulated GLP-1 secretion by enteric neural net in Wistar rat Biomed Res Int 2014 2014 923564 25247193
   PubMed Web of Science ®Google Scholar
• Garcia-Galiano D Tena-Sempere M Emerging roles of NUCB2/nesfatin-1 in the metabolic control of reproduction Curr Pharm Des 2013 19 6966 6972 23537080
   PubMed Web of Science ®Google Scholar
• Cota D Marsicano G Lutz B Endogenous cannabinoid system as a modulator of food intake Int J Obes Relat Metab Disord 2003 27 289 301 12629555
   PubMed Web of Science ®Google Scholar
• Pazos MR Tolon RM Benito C Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa J Histochem Cytochem 2008 56 511 516 18285348
   PubMed Web of Science ®Google Scholar
• Khamzina L Veilleux A Bergeron S Marette A Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance Endocrinology 2005 146 1473 1481 15604215
   PubMed Web of Science ®Google Scholar
• Senin LL Al-Massadi O Folgueira C The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake PLoS One 2013 8 e80339 24303008
   PubMed Web of Science ®Google Scholar
• Li Z Xu G Li Y mTOR-dependent modulation of gastric nesfatin-1/NUCB2 Cell Physiol Biochem 2012 29 493 500 22508056
   PubMed Web of Science ®Google Scholar
• United States Department of Health and Human Services. United States. Department of Agriculture. Dietary Guidelines Advisory Committee Dietary Guidelines for Americans, 2010 Washington, DC Government Printing Office 2010 xi 95
   Google Scholar
• Jakicic JM The effect of physical activity on body weight Obesity (Silver Spring) 2009 17 Suppl 3 S34 S38 19927144
   PubMed Web of Science ®Google Scholar
• Kral JG Naslund E Surgical treatment of obesity Nat Clin Pract Endocrinol Metab 2007 3 574 583 17643128
   PubMedGoogle Scholar
• Sjostrom L Narbro K Sjostrom CD Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 2007 357 741 752 17715408
   PubMed Web of Science ®Google Scholar
• Lopez M Seoane LM Tovar S Orexin-A regulates growth hormone-releasing hormone mRNA content in a nucleus-specific manner and somatostatin mRNA content in a growth hormone-dependent fashion in the rat hypothalamus Eur J Neurosci 2004 19 2080 2088 15090035
   PubMed Web of Science ®Google Scholar
• Ioannides-Demos LL Proietto J McNeil JJ Pharmacotherapy for obesity Drugs 2005 65 1391 1418 15977970
   PubMed Web of Science ®Google Scholar
• Bai B Wang Y The use of lorcaserin in the management of obesity: a critical appraisal Drug Des Devel Ther 2010 5 1 7
   PubMed Web of Science ®Google Scholar
• Kirilly E Gonda X Bagdy G CB1 receptor antagonists: new discoveries leading to new perspectives Acta Physiol (Oxf) 2012 205 41 60 22463610
   PubMed Web of Science ®Google Scholar
• Yanovski SZ Yanovski JA Long-term drug treatment for obesity: a systematic and clinical review JAMA 2014 311 74 86 24231879
   PubMed Web of Science ®Google Scholar
• Bluher M Adipokines–removing road blocks to obesity and diabetes therapy Mol Metab 2014 3 230 240 24749053
   PubMed Web of Science ®Google Scholar
• Bauche IB El Mkadem SA Pottier AM Overexpression of adiponectin targeted to adipose tissue in transgenic mice: impaired adipocyte differentiation Endocrinology 2007 148 1539 1549 17204560
   PubMed Web of Science ®Google Scholar
• Yamauchi T Kamon J Waki H Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis J Biol Chem 2003 278 2461 2468 12431986
   PubMed Web of Science ®Google Scholar
• Ahima RS Flier JS Leptin Annu Rev Physiol 2000 62 413 437 10845097
   PubMed Web of Science ®Google Scholar
• Savage DB O’Rahilly S Leptin: a novel therapeutic role in lipodystrophy J Clin Invest 2002 109 1285 1286 12021242
   PubMed Web of Science ®Google Scholar
• Foo JP Mantzoros CS Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: a need for more mechanistic studies and large, randomized, placebo-controlled trials Metabolism 2012 61 1331 1336 22592129
   PubMed Web of Science ®Google Scholar
• Chou K Perry CM Metreleptin: first global approval Drugs 2013 73 989 997 23740412
   PubMed Web of Science ®Google Scholar
• Muller TD Sullivan LM Habegger K Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21 J Pept Sci 2012 18 383 393 22565812
   PubMed Web of Science ®Google Scholar
• Okamoto Y Folco EJ Minami M Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis Circ Res 2008 102 218 225 17991878
   PubMed Web of Science ®Google Scholar
• Kusminski CM Scherer PE The road from discovery to clinic: adiponectin as a biomarker of metabolic status Clin Pharmacol Ther 2009 86 592 595 19915603
   PubMed Web of Science ®Google Scholar
• Heiker JT Kloting N Kovacs P Vaspin inhibits kallikrein 7 by serpin mechanism Cell Mol Life Sci 2013 70 2569 2583 23370777
   PubMed Web of Science ®Google Scholar
• Lotfy M Singh J Kalasz H Tekes K Adeghate E Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus Open Med Chem J 2011 5 82 92 21966329
   PubMedGoogle Scholar
• Saito M Okamatsu-Ogura Y Matsushita M High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity Diabetes 2009 58 1526 1531 19401428
   PubMed Web of Science ®Google Scholar
• Al-Massadi O Pardo M Casanueva FF Seoane LM The stomach as an energy homeostasis regulating center. An approach for obesity Recent Pat Endocr Metab Immune Drug Discovery 2010 4 75 84
   Google Scholar
• Kim GW Lin JE Blomain ES Waldman SA Antiobesity pharmacotherapy: new drugs and emerging targets Clin Pharmacol Ther 2014 95 53 66 24105257
   PubMed Web of Science ®Google Scholar
• Ravussin E Gautier JF Metabolic predictors of weight gain Int J Obes Relat Metab Disord 1999 23 Suppl 1 37 41 10193860
   PubMed Web of Science ®Google Scholar